Endoscopic weight loss: comparing EndoZip and Apollo ESG
Part of Hormones & metabolism clinical trials.
This study compares two different endoscopic procedures (EndoZip and Apollo ESG) to help obese patients lose weight. Both are done through the mouth without cutting the skin, and the goal is to see which works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 65 years old.
- Your BMI must be between 30 and 50 (severe obesity).
- You must have tried and failed other weight-loss methods that were not surgery.
- You cannot have had any prior stomach, esophagus, or weight-loss surgery.
- You must be willing to follow a strict diet and behavioral program for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help people with obesity lose weight. A doctor uses a thin tube with a camera to stitch your stomach smaller, so you feel full sooner.
This study tests a new procedure called endoscopic sleeve gastroplasty with fundal mucosal ablation to help with weight loss. It is an option for people with obesity who have not had success with other methods and who have not had prior stomach surgery.
This study compares two similar minimally invasive procedures to help with weight loss. The goal is to see which technique is safer and more effective for people with a high body mass index (BMI).
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This trial tests a new device called the ENDOPLY system, which is placed inside the stomach through a tube in the mouth to help with weight loss. It is for people who have struggled with dieting and have a BMI between 30 and 40.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.